Krieger S |
Multiple sclerosis therapeutic pipeline: opportunities and challenges. |
|
Mt. Sinai J. Med. |
pmid:21425264
|
Derwenskus J |
Current disease-modifying treatment of multiple sclerosis. |
|
Mt. Sinai J. Med. |
pmid:21425262
|
Li XK et al. |
FTY720, a novel immunosuppressive agent, enhances upregulation of the cell adhesion molecular ICAM-1 in TNF-alpha treated human umbilical vein endothelial cells. |
|
Transplant. Proc. |
pmid:9123298
|
Fujino M et al. |
T-cell apoptosis triggered by FTY720 via mitochondrial pathway. |
|
Transplant. Proc. |
pmid:11750325
|
Kahan BD |
FTY720: a new dimension in transplantation. |
|
Transplant. Proc. |
pmid:11750324
|
Brinkmann V et al. |
FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects. |
|
Transplant. Proc. |
pmid:11750323
|
Chen S et al. |
FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines. |
|
Transplant. Proc. |
pmid:11750317
|
Troncoso P et al. |
FTY 720 prevents ischemic reperfusion damage in rat kidneys. |
|
Transplant. Proc. |
pmid:11267102
|
Pin D et al. |
An emulsion restores the skin barrier by decreasing the skin pH and inflammation in a canine experimental model. |
|
J. Comp. Pathol. |
pmid:24975893
|
Duan RD |
Anticancer compounds and sphingolipid metabolism in the colon. |
|
In Vivo |
pmid:15796189
|